These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32218998)

  • 41. Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine.
    Manukyan H; Wahid R; Ansari A; Tritama E; Macadam A; Konz J; Chumakov K; Laassri M
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM
    Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C; Ogawa T; Shirasawa H
    Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Live attenuated oral poliovirus vaccine.
    Melnick JL
    Rev Infect Dis; 1984; 6 Suppl 2():S323-7. PubMed ID: 6330836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama.
    Rojas-Bonilla M; Coulliette-Salmond A; Belgasmi H; Wong K; Sayyad L; Vega E; Grimoldi F; Oberste MS; Rüttimann R
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
    Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J
    J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.
    Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N
    BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.
    Bakker WA; Thomassen YE; van't Oever AG; Westdijk J; van Oijen MG; Sundermann LC; van't Veld P; Sleeman E; van Nimwegen FW; Hamidi A; Kersten GF; van den Heuvel N; Hendriks JT; van der Pol LA
    Vaccine; 2011 Sep; 29(41):7188-96. PubMed ID: 21651934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An economic analysis of poliovirus risk management policy options for 2013-2052.
    Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():389. PubMed ID: 26404632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From vaccine to pathogen: Modeling Sabin 2 vaccine virus reversion and evolutionary epidemiology in Matlab, Bangladesh.
    Wong W; Gauld J; Famulare M
    Virus Evol; 2023; 9(2):vead044. PubMed ID: 37692896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.
    Adu F; Iber J; Bukbuk D; Gumede N; Yang SJ; Jorba J; Campagnoli R; Sule WF; Yang CF; Burns C; Pallansch M; Harry T; Kew O
    Virus Res; 2007 Jul; 127(1):17-25. PubMed ID: 17449127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.
    Jorba J; Diop OM; Iber J; Henderson E; Sutter RW; Wassilak SGF; Burns CC
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1185-1191. PubMed ID: 29095803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poliovirus vaccine strains in sewage and river water in South Africa.
    Pavlov DN
    Can J Microbiol; 2006 Aug; 52(8):717-23. PubMed ID: 16917529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.
    Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
    BMC Infect Dis; 2016 Mar; 16():137. PubMed ID: 27009272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel gamma radiation-inactivated sabin-based polio vaccine.
    Tobin GJ; Tobin JK; Gaidamakova EK; Wiggins TJ; Bushnell RV; Lee WM; Matrosova VY; Dollery SJ; Meeks HN; Kouiavskaia D; Chumakov K; Daly MJ
    PLoS One; 2020; 15(1):e0228006. PubMed ID: 31999745
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019.
    Moffett DB; Llewellyn A; Singh H; Saxentoff E; Partridge J; Iakovenko M; Roesel S; Asghar H; Baig N; Grabovac V; Gurung S; Gumede-Moeletsi N; Barnor J; Theo A; Rey-Benito G; Villalobos A; Boualam L; Swan J; Sutter RW; Pandel E; Wassilak S; Oberste MS; Lewis I; Zaffran M;
    MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(38):825-829. PubMed ID: 31557146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.